Caresyntax Platform
AI-powered surgical intelligence platform for data-driven operating room optimization
Platform · HybridCompany source
Company profile
About Caresyntax
Transforms OR data into actionable insights with a vendor-neutral platform built to optimize workflows and drive high-impact OR performance, making surgery safer and smarter.
Company description Caresyntax official website
Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Work at Caresyntax?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- surgical procedures
Who it serves
- Health Systems
- Hospitals
- Medical Device Companies
Deployment & integration
Hybrid deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Safety and efficacy of AirSeal® continuous pressure insufflator for pneumoperitoneum maintenance in minimally invasive pediatric urologic surgery.Journal of pediatric urology · Feb 1, 2026
New synthetic resorbable mesh for open ventral hernia repair: the multicentre, single-arm, prospective study of Transorb self-gripping resorbable mesh in subjects undergoing open repair of ventral hernia in clean and clean-contaminated fields (RECOVER) protocol.BMJ open · Jul 17, 2025
Development and preliminary validation of a new task-based objective procedure-specific assessment of inguinal hernia repair procedural safety.Surgical endoscopy · Mar 1, 2024
A multi-national, video-based qualitative study to refine training guidelines for assigning an "unsafe" score in laparoscopic cholecystectomy critical view of safety.Surgical endoscopy · Feb 1, 2024
Laparoscopic cholecystectomy critical view of safety (LC-CVS): a multi-national validation study of an objective, procedure-specific assessment using video-based assessment (VBA).Surgical endoscopy · Feb 1, 2024
Using video-based assessment (VBA) to document fellow improvement in safely completing the jejunojejunostomy portion of laparoscopic Roux-en-Y gastric bypass (RYGB) surgery.Surgical endoscopy · Nov 1, 2023
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
improved surgical outcomes
through data-driven insights
increased efficiency
operating room operations
enhanced safety
surgical procedures
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Matt Krueger
Chief Executive Officer
Dennis Kogan
Founder | Board Committees | Managing Director
Stephen Gordon
Vice President of Software Engineering
Michael Doran
Vice President, Commercial Partnerships
Jonathan Hart
Vice President, Solution Strategy
Rebecca Jeglum, SPHR, SHRM-CP, FPC
Global Vice President, Human Resources
Ronan Blanchard
Chief Financial Officer
Bruce Ramshaw
CMIO
06 · Company updates
Updates from Caresyntax
Recent articles published on Caresyntax's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Surgical AI & Robotics
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.